Wikidata

(Q46484712)

English

Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.

scientific article published on 14 July 2008

In more languages

Statements

title
Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18626007
retrieved
22 December 2017
reference URL
http://europepmc.org/abstract/MED/18626007
author name string
National Cancer Institute of Canada Clinical Trials Group Study BR.21
series ordinal
15
1 reference
stated in
Europe PubMed Central
PubMed ID
18626007
retrieved
22 December 2017
reference URL
http://europepmc.org/abstract/MED/18626007

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46484712&oldid=1426964714"